September 2022 - Bionest

26

Sep 2022

Bionest

ASCO 2022 – Part 2: Vanishing dMMR Rectal Cancer; Predicting Cytokine Release Syndrome Risk

Could dostarlima spare some colorectal cancer patients from chemo? Is it possible to predict which CAR-T patients are at risk of CRS? More ASCO highlights.

19

Sep 2022

Bionest

ASCO 2022 – Part 1: Redefining Breast Cancer Classification and Treatment

An important new development in breast cancer greatly expands the number of patients who might benefit from HER2-targeting treatment, as shared at ASCO 2022

6

Sep 2022

Bionest

Potential Game Changers in Diabetes and Obesity

Is metformin on the way out as a first-line therapy for type 2 diabetes, to be replaced by tirzepatide? We examine new treatments for diabetes and obesity.